Mumbai, May 18 Consumer wellness company Zydus Wellness Limited, which owns brands such as Sugar Free and Glucon-D, on Monday reported a nearly halved profit for FY26.
The company’s consolidated net profit for the financial year fell 47 per cent year-on-year to Rs 197 crore, even as consolidated net sales rose 46.4 per cent to Rs 3,940 crore.
For the March quarter, consolidated net profit declined nearly 6 per cent year-on-year to Rs 162 crore, according to its stock exchange filing.
However, consolidated revenue from operations surged 62.1 per cent to around Rs 1,476 crore compared to the corresponding quarter last financial year.
The company said topline growth during the year was driven by contributions from newly acquired businesses, although profitability remained under pressure due to integration-related expenses and higher operational costs.
Operating performance remained relatively stable, with EBITDA rising 34.2 per cent year-on-year to Rs 509 crore during FY26.
The board of directors recommended a final dividend of Rs 1.20 per equity share of face value Rs 2 for the financial year, subject to shareholder approval at the annual general meeting scheduled for August 4.
Among its key brands, the company said Sugar Free maintained its dominance in the sugar substitute category with a market share of 96.1 per cent.
The brand also expanded into adjacent categories through new launches, including Sugar Free D’lite Choco Spread.
Protein snacking brand RiteBite Max Protein continued to scale up operations and improved profitability to near double-digit EBITDA margins.
The company attributed the improvement to new product introductions such as protein drinks and functional snack bars.
Hydration brand Glucon-D retained leadership in its segment with a 58.9 per cent market share while also expanding into performance hydration products.
In the skincare segment, Everyuth maintained strong market positions across scrubs and peel-off masks, while Nycil continued to lead the prickly heat powder category.
The company added that its broader nutraceutical and wellness portfolio, including brands such as Nutralite and Complan, continued to witness steady momentum during the year, although overall earnings remained impacted by cost pressures and integration expenses linked to acquisitions.
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor